Table 1.
Assessment of haematological response pre- and post-renal transplantation and its impact on overall survival.
| Pre-Renal Transplantation | Post-Renal Transplantation | |||
|---|---|---|---|---|
| OS from renal transplant | P value | OS from renal transplant | P value | |
| CR | 123.9 (72.8–143.2) months | 0.015 | 137.8 (113.3–161.6) months | 0.0001 |
| VGPR or worse | 70.4 (38.4–117.6) months | 58.9 (34.4–91.6) months | ||
| dFLC >90% reduction | 114.4 (47.6–140.4) months | 0.602 | 133.5 (109.3–158.4) months | 0.0001 |
| dFLC <90% reduction2 | 92.9 (63.9–122.1) months | 64.4 (41.9–114.1) months | ||
| dFLC <10 mg/L | Nil Patients | 137.8 (112.4–163.2) months | 0.0001 | |
| dFLC >10 mg/L14 | 68.5 (58.7–97.3) months | |||
| iFLC <20 mg/L | Nil Patients | 150.3 (126.2–174.4) months | 0.034 | |
| iFLC >20 mg/L15 | 84.3 (58.9–103.1) months | |||
SFLC serum free light chain, OS overall survival, CR complete response, VGPR very good partial response, dFLC difference in free light chains, iFLC involved free light chains.